Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.590
+0.070 (2.78%)
Dec 20, 2024, 4:00 PM EST - Market closed
Boundless Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 16.42 | 12.16 | 9.31 | 6.02 |
| Research & Development | 52.37 | 42.64 | 37.16 | 19.28 |
| Operating Expenses | 68.79 | 54.8 | 46.47 | 25.3 |
| Operating Income | -68.79 | -54.8 | -46.47 | -25.3 |
| Interest & Investment Income | 7.6 | 5.28 | 0.67 | 0.1 |
| Other Non Operating Income (Expenses) | 0.13 | 0.08 | -0.1 | -0.01 |
| Pretax Income | -61.06 | -49.43 | -45.9 | -25.21 |
| Net Income | -61.06 | -49.43 | -45.9 | -25.21 |
| Net Income to Common | -61.06 | -49.43 | -45.9 | -25.21 |
| Shares Outstanding (Basic) | 12 | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 12 | 1 | 1 | 1 |
| Shares Change (YoY) | 881.66% | 10.78% | 27.56% | - |
| EPS (Basic) | -5.21 | -40.65 | -41.81 | -29.29 |
| EPS (Diluted) | -5.21 | -40.65 | -41.81 | -29.29 |
| Free Cash Flow | -59.3 | -47.49 | -40.66 | -25.28 |
| Free Cash Flow Per Share | -5.06 | -39.05 | -37.04 | -29.38 |
| EBITDA | -67.75 | -53.84 | -45.53 | -24.62 |
| D&A For EBITDA | 1.04 | 0.96 | 0.94 | 0.68 |
| EBIT | -68.79 | -54.8 | -46.47 | -25.3 |
Source: S&P Capital IQ. Standard template.
Financial Sources.